financetom
Business
financetom
/
Business
/
Rambus Insider Sold Shares Worth $958,900, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rambus Insider Sold Shares Worth $958,900, According to a Recent SEC Filing
Nov 12, 2025 11:55 AM

02:13 PM EST, 11/12/2025 (MT Newswires) -- Eric B Stang, Director, on November 07, 2025, sold 9,000 shares in Rambus ( RMBS ) for $958,900. Following the Form 4 filing with the SEC, Stang has control over a total of 24,218 common shares of the company, with 3,824 shares held directly and 20,394 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/917273/000119312525277055/xslF345X05/ownership.xml

Price: 102.70, Change: -2.24, Percent Change: -2.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
India's Embassy REIT plans to raise up to $400 mln, hires banks, sources say
India's Embassy REIT plans to raise up to $400 mln, hires banks, sources say
Apr 2, 2024
* Office developer Embassy targets June deal, sources say * Embassy plans to raise funds via QIP, sources say * Deal comes amid India real estate boom, surging demand By M. Sriram MUMBAI, April 2 (Reuters) - India's largest real estate investment trust, Embassy Office Parks, plans to raise up to $400 million from investors, two sources with direct knowledge...
Hutchmed, Innovent Biologics Say Chinese Regulator Accepts Application for Endometrial Cancer Drug Combination
Hutchmed, Innovent Biologics Say Chinese Regulator Accepts Application for Endometrial Cancer Drug Combination
Apr 2, 2024
04:10 AM EDT, 04/02/2024 (MT Newswires) -- Hutchmed ( HCM ) and Innovent Biologics said Tuesday a new drug application for the sintilimab-fruquintinib combination for the treatment of advanced endometrial cancer has been accepted by the China National Medical Products Administration with a priority review status. The filing was supported by data from a phase 2 trial which evaluated the...
Bank of China says net interest margin will continue to face pressure
Bank of China says net interest margin will continue to face pressure
Apr 2, 2024
BEIJING (Reuters) - Bank of China ( BACHF ) said its net interest margin - a key gauge of profitability - will still face significant pressure this year. Vice President Zhang Yi made the remarks in an earnings press conference on Tuesday. ...
Whirlpool Completes Formation of Beko Europe With Arcelik
Whirlpool Completes Formation of Beko Europe With Arcelik
Apr 2, 2024
04:00 AM EDT, 04/02/2024 (MT Newswires) -- Whirlpool (WHR) said early Tuesday it has finalized a deal with appliance maker Arcelik to create a new European appliance and consumer electronics company, called Beko Europe. The new company combines Whirlpool's European major domestic appliance business with Arcelik's European appliance and consumer electronics businesses. Whirlpool retains a 25% stake in Beko, with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved